NewsRoom Articles - Page 64 of 207

WednesdayJun 14, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Announces Positive Data From Phase 1 Clinical Trial Evaluating REQORSA(R) Immunogene Therapy for Late-Stage Non-Small Cell Lung Cancer

The positive data from the Acclaim-1 Phase 1 portion of the Phase 1/2 clinical trial has been published in an abstract at the 2023 American Society of Clinical Oncology Annual Meeting, which took place in Chicago, IL and online June 2 – 6, 2023 Acclaim-1 is an open-label, multi-center Phase 1/2 clinical trial evaluating REQORSA(R) in combination with Tagrisso(R) The Phase 2 expansion portion of the study is expected to enroll approximately 66 patients – half of which will have only received Tagrisso(R) and the other half receiving Tagrisso(R) and chemotherapy The global lung cancer treatment market is expected to…

TuesdayJun 13, 2023 10:29 am

Researchers Explain How Brain Cancers Hijack Neural Circuits

Estimates from the National Brain Tumor Society show that about 700,000 individuals in the United States live with primary brain tumors. With a relative survival rate of 35.7%, malignant brain tumors are among the deadliest types of cancers. Although there are more than 100 types of brain cancers, glioblastoma multiforme (GBM) tends to have the most severe health outcomes. Left untreated, this aggressive brain tumor can be fatal in as little as six months. There is currently no cure for GBM, and treatment efforts are currently focused on controlling the tumor and maintaining the patient’s quality of life. For as…

MondayJun 12, 2023 9:21 am

Transplant Medicine Plagued by Organ Shortages, Pandemic-Induced Challenges

In November 2022, more than 100,000 Americans were on the organ transplant list eagerly awaiting an organ. But with the United States having just only approximately 20,000 organ donors, a large portion of people on the organ transplant list have to wait for months or even years. Still, the National Organ Procurement and Transplantation Network notes that 2022 was a record year for organ transplants in America, with the number of transplants increasing by 3.7% to 42,887 transplants. Despite last year’s performance, the transplant medicine field is still grappling with major issues that are preventing it from functioning at peak…

FridayJun 09, 2023 1:17 pm

Deliberate UX/UI Design Boosts eCommerce Customer Satisfaction, Sales

E-commerce is the new frontier of trade. Companies such as Amazon have revolutionized trade in only a few decades and are now among the largest and most profitable companies on the globe. The internet granted businesses something they didn’t have for decades — a much wider reach both in terms of customers and potential partnerships. However, even though billions of people globally buy online, flourishing within the e-commerce sector is not an easy task. Businesses in this sector have a failure rate of around 80%–90%, and a lot of these failures can be traced back to poor UX/UI design. User…

ThursdayJun 08, 2023 2:46 pm

Scientists Close to Treating Hearing Loss Using Gene Therapy

Around 24.5 million people in the United States, aged 12 years and older, suffer from mild hearing loss while 10.7 million people 12 years and older live with moderate hearing loss. Up to 1.8 million people older than 11 years in the country suffer from moderate hearing loss while more than 400 million people worldwide have some degree of hearing loss. Although there is currently no cure for age-related hearing loss, people can use listening devices, such as hearing aids, to reduce the severity of the condition. In most cases, most of these people suffer from sensorineural hearing loss, which…

WednesdayJun 07, 2023 1:47 pm

Scientists Create Open-Source Platform to Analyze Brain Tumors in Kids

Every year, around 2,200 children and adolescents in the United States receive brain tumor diagnoses. Brain tumors rarely occur in these age groups, and most children and adolescents diagnosed with brain tumors grow into adulthood. However, even though pediatric brain tumors are relatively rare, they are among the leading causes of death in children in the country. Furthermore, even less deadly brain tumor variants with longer survival rates negatively affect the diagnosed children and their families. As such, researchers are constantly working on better diagnosing, analyzing and treating brain tumors to improve treatment outcomes even further. Recent efforts by a…

TuesdayJun 06, 2023 3:07 pm

New Computational Platform to Broaden Options of Potential Immunotherapy Targets in Cancer Treatment

Immunotherapy is a relatively novel way of treating cancer. It entails boosting one’s immune system so it can locate and destroy cancer cells. This type of treatment is typically recommended for patients suffering from cases of advanced cancer, and it can be used to address conditions such as kidney cancer, lymphoma, bladder cancer and non-small cell lung cancer. Since immunotherapy has only been around since the 1980s, researchers and clinicians are constantly working to make the treatment safer and more effective for cancer patients. A team of researchers from UCLA and the Children’s Hospital of Philadelphia (CHOP) have now created…

MondayJun 05, 2023 1:59 pm

Why Healthcare Should Adopt Merchandising Practices

Healthcare has gone through several evolutions throughout the course of human history. Our first attempts at treating medical conditions were half-hearted at best and hampered by our ignorance of germ theory and human biology. The acceptance of germ theory paved the way for modern healthcare and allowed humanity to treat previously fatal injuries and conditions, extending our lifetimes and giving people much longer lifespans. The medical field continued to develop in tandem with technology, adapting more and more complex technology into the field to enhance research and develop a wide variety of medications. With the internet and e-commerce now entrenched…

FridayJun 02, 2023 11:50 am

Initial Evidence Suggests Possible Link Between COVID-19, Tinnitus

The coronavirus pandemic threw the entire world into a lurch and showed us just how difficult it can be to deal with a pandemic in our increasingly connected world. A few months after the virus was first discovered in Wuhan, China, dozens of countries shut down their borders to stop the disease from spreading at the cost of economic activity. The coronavirus vaccine appears to have been instrumental in stopping COVID-19 infections, reducing negative health outcomes and opening up the world to international activity once again. However, although we are now through the worst of the pandemic, infections are still…

FridayJun 02, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Displays CDMO Expertise at Prestigious Biomed Israel Conference

Biotechnology innovator BiondVax Pharmaceuticals is dedicated to developing nanosized antibody (NanoAb) treatment BiondVax is also leveraging its team experience in preclinical stage to Phase 3 clinical trial product development to generate new revenues by offering cGMP contract development and manufacturing organization (“CDMO”) services The company recently exhibited its CDMO expertise as well as its NanoAb development pipeline at the 21st annual Biomed Israel conference, which drew over 6,000 attendees from a wide variety of international life sciences disciplines BiondVax’s NanoAb drug candidate pipeline has expanded focus on immune system cytokine targets for treating psoriasis and psoriatic arthritis Israel-based biotechnology company…